abstract |
The present invention relates to an anticancer composition comprising a recombinant vector containing a genetic construct encoding IL- 12M and a recombinant vector containing a gene encoding an immune regulatory factor or an anticancer composition comprising a recombinant vector containing a genetic construct encoding IL- 12M and an immune regulatory gene in combination, and a method for enhancing immune responses and suppressing proliferation of tumor cells, in which the anticancer composition is administered to a subject in need of anticancer treatment so as to express each gene in the subject. The present invention provides improved anticancer effects than the conventional anticancer composition. |